| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiniksa Pharmaceuticals International, Plc (KNSA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. KNSA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.2K | $34.51M | - | |
| Other | 143.9K | $7.93M | - | |
| Dir | 36.5K | $2.01M | - | |
| COO | 28.7K | $1.58M | - | |
| CFO | 22.8K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2025 | Megna Michael R | Chief Accounting Officer | Sale+OE | 17,647 | $26.69 | $470,998.43 | -35.2% | +23.5% | +112.7% | |
| May 5, 2025 | Moat Ross | Chief Commercial Officer | Sale+OE | 10,122 | $28.00 | $283,416.00 | -35.0% | +18.6% | +104.2% | |
| May 1, 2025 | Moat Ross | Chief Commercial Officer | Sale+OE | 87,269 | $25.96 | $2,265,339.03 | -82.3% | +8.4% | +99.2% | |
| May 1, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 88,395 | $26.56 | $2,347,335.10 | -52.2% | +8.4% | +99.2% | |
| Apr 21, 2025 | Moat Ross | Chief Commercial Officer | Sell | 18,259 | $20.29 | $370,475.11 | -66.0% | +41.7% | - | |
| Apr 14, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE | 12,000 | $20.48 | $245,811.55 | -6.9% | +39.2% | +127.5% | |
| Mar 20, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 15,944 | $23.11 | $368,465.84 | -40.5% | +17.3% | +93.5% | |
| Mar 19, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 20,343 | $23.10 | $469,923.30 | -30.3% | +21.1% | +97.7% | |
| Mar 12, 2025 | Megna Michael R | Chief Accounting Officer | Sale+OE | 9,051 | $22.45 | $203,194.95 | -25.4% | +32.3% | +104.8% | |
| Mar 12, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE | 36,372 | $22.25 | $809,277.00 | -61.3% | +32.3% | +104.8% |